vs
Side-by-side financial comparison of Origin Bancorp, Inc. (OBK) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
Origin Bancorp, Inc. is the larger business by last-quarter revenue ($104.0M vs $76.2M, roughly 1.4× VIEMED HEALTHCARE, INC.). Origin Bancorp, Inc. runs the higher net margin — 26.6% vs 7.4%, a 19.2% gap on every dollar of revenue. Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 3.9%).
Southern Bancorp is a community development financial institution headquartered in Arkadelphia, Arkansas. It was founded in 1986 as Southern Development Bancorporation, and is often referred to simply as "Southern".
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
OBK vs VMD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $104.0M | $76.2M |
| Net Profit | $27.7M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | — | 11.0% |
| Net Margin | 26.6% | 7.4% |
| Revenue YoY | — | 25.5% |
| Net Profit YoY | — | 30.7% |
| EPS (diluted) | $0.89 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $104.0M | — | ||
| Q4 25 | $103.4M | $76.2M | ||
| Q3 25 | $109.8M | $71.9M | ||
| Q2 25 | $83.5M | $63.1M | ||
| Q1 25 | $94.1M | $59.1M | ||
| Q4 24 | $78.3M | $60.7M | ||
| Q3 24 | $90.8M | $58.0M | ||
| Q2 24 | $96.4M | $55.0M |
| Q1 26 | $27.7M | — | ||
| Q4 25 | $29.5M | $5.6M | ||
| Q3 25 | $8.6M | $3.5M | ||
| Q2 25 | $14.6M | $3.2M | ||
| Q1 25 | $22.4M | $2.6M | ||
| Q4 24 | $14.3M | $4.3M | ||
| Q3 24 | $18.6M | $3.9M | ||
| Q2 24 | $21.0M | $1.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% |
| Q1 26 | — | — | ||
| Q4 25 | 36.2% | 11.0% | ||
| Q3 25 | 10.0% | 7.8% | ||
| Q2 25 | 22.3% | 8.1% | ||
| Q1 25 | 30.4% | 6.5% | ||
| Q4 24 | 23.0% | 10.6% | ||
| Q3 24 | 26.1% | 9.7% | ||
| Q2 24 | 27.7% | 6.6% |
| Q1 26 | 26.6% | — | ||
| Q4 25 | 28.5% | 7.4% | ||
| Q3 25 | 7.9% | 4.9% | ||
| Q2 25 | 17.5% | 5.0% | ||
| Q1 25 | 23.8% | 4.4% | ||
| Q4 24 | 18.2% | 7.1% | ||
| Q3 24 | 20.5% | 6.7% | ||
| Q2 24 | 21.8% | 2.7% |
| Q1 26 | $0.89 | — | ||
| Q4 25 | $0.95 | $0.14 | ||
| Q3 25 | $0.27 | $0.09 | ||
| Q2 25 | $0.47 | $0.08 | ||
| Q1 25 | $0.71 | $0.06 | ||
| Q4 24 | $0.45 | $0.10 | ||
| Q3 24 | $0.60 | $0.10 | ||
| Q2 24 | $0.67 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $141.5M |
| Total Assets | $10.2B | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $424.2M | $13.5M | ||
| Q3 25 | $626.9M | $11.1M | ||
| Q2 25 | $334.1M | $20.0M | ||
| Q1 25 | $486.2M | $10.2M | ||
| Q4 24 | $470.2M | $17.5M | ||
| Q3 24 | $321.2M | $11.3M | ||
| Q2 24 | $288.1M | $8.8M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.2B | $141.5M | ||
| Q3 25 | $1.2B | $133.6M | ||
| Q2 25 | $1.2B | $139.7M | ||
| Q1 25 | $1.2B | $134.8M | ||
| Q4 24 | $1.1B | $131.4M | ||
| Q3 24 | $1.1B | $125.0M | ||
| Q2 24 | $1.1B | $119.4M |
| Q1 26 | $10.2B | — | ||
| Q4 25 | $9.7B | $199.2M | ||
| Q3 25 | $9.8B | $202.4M | ||
| Q2 25 | $9.7B | $184.6M | ||
| Q1 25 | $9.8B | $178.1M | ||
| Q4 24 | $9.7B | $177.1M | ||
| Q3 24 | $10.0B | $169.5M | ||
| Q2 24 | $9.9B | $163.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $18.4M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $158.9M | $18.4M | ||
| Q3 25 | $59.3M | $18.4M | ||
| Q2 25 | $20.6M | $12.3M | ||
| Q1 25 | $35.6M | $2.9M | ||
| Q4 24 | $108.5M | $15.0M | ||
| Q3 24 | $39.6M | $12.7M | ||
| Q2 24 | $11.9M | $10.2M |
| Q1 26 | — | — | ||
| Q4 25 | $151.1M | $9.7M | ||
| Q3 25 | $56.8M | $10.7M | ||
| Q2 25 | $19.6M | $4.1M | ||
| Q1 25 | $34.8M | $-12.6M | ||
| Q4 24 | $86.4M | $3.2M | ||
| Q3 24 | $32.2M | $1.7M | ||
| Q2 24 | $6.5M | $1.2M |
| Q1 26 | — | — | ||
| Q4 25 | 146.0% | 12.7% | ||
| Q3 25 | 51.7% | 14.9% | ||
| Q2 25 | 23.5% | 6.5% | ||
| Q1 25 | 37.0% | -21.4% | ||
| Q4 24 | 110.3% | 5.2% | ||
| Q3 24 | 35.5% | 3.0% | ||
| Q2 24 | 6.8% | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | 11.5% | ||
| Q3 25 | 2.3% | 10.6% | ||
| Q2 25 | 1.2% | 12.9% | ||
| Q1 25 | 0.8% | 26.2% | ||
| Q4 24 | 28.1% | 19.5% | ||
| Q3 24 | 8.1% | 19.0% | ||
| Q2 24 | 5.6% | 16.3% |
| Q1 26 | — | — | ||
| Q4 25 | 5.38× | 3.27× | ||
| Q3 25 | 6.88× | 5.23× | ||
| Q2 25 | 1.41× | 3.88× | ||
| Q1 25 | 1.59× | 1.09× | ||
| Q4 24 | 7.60× | 3.47× | ||
| Q3 24 | 2.13× | 3.29× | ||
| Q2 24 | 0.57× | 6.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OBK
| Net Interest Income | $87.2M | 84% |
| Noninterest Income | $16.8M | 16% |
VMD
Segment breakdown not available.
